Literature DB >> 17630239

The impurity characteristics of methamphetamine synthesized by Emde and Nagai method.

Beom Jun Ko1, Sungill Suh, Yong Jun Suh, Moon Kyo In, Sung-Hong Kim.   

Abstract

Impurity profiling and classification of seized methamphetamine may play an important role in the interpretation of analytical results, the determination of the synthetic method employed, and the criminal investigations of drug traffic routes. Our study is focused on classifying seized methamphetamine samples according to the groups sorted by the types and quantities of impurities present in illicit methamphetamine samples. The samples (100mg) were dissolved in 2 mL of potassium phosphate buffer (pH 7.0), extracted with 200 microL of ethyl acetate under basic condition, and then analyzed by gas chromatography-mass spectrometry (GC-MS) with a DB-1 capillary column (30 m x 0.25 mm i.d., 0.25 microm). Five impurities are used as criteria for the classification of seized methamphetamine samples by Emde and Nagai method. A total of fifty-two samples of seized methamphetamine were analyzed by GC-MS and classified by five organic impurities, and then sorted into four groups, which are Nagai type, Emde Type, Undetermined I type, and Undetermined II type.

Entities:  

Year:  2007        PMID: 17630239     DOI: 10.1016/j.forsciint.2007.03.029

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 0379-0738            Impact factor:   2.395


  2 in total

1.  Identification of impurities and statistical classification of methamphetamine hydrochloride drugs seized in China.

Authors:  Jian Xin Zhang; Da Ming Zhang; Xu Guang Han
Journal:  Forensic Sci Int       Date:  2008-11-12       Impact factor: 2.395

2.  Characterization of route specific impurities found in methamphetamine synthesized by the Leuckart and reductive amination methods.

Authors:  Vanitha Kunalan; Niamh Nic Daéid; William J Kerr; Hilary A S Buchanan; Allan R McPherson
Journal:  Anal Chem       Date:  2009-09-01       Impact factor: 6.986

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.